Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma

SIMPLE SUMMARY: The survival of advanced melanoma patients has been improved in recent years due to immunotherapy. However, not all patients respond to this treatment. For this reason, it is necessary to know the mechanisms of the response and resistance to immunotherapy. In this work, clinical samp...

Descripción completa

Detalles Bibliográficos
Autores principales: Trilla-Fuertes, Lucía, Gámez-Pozo, Angelo, Prado-Vázquez, Guillermo, López-Vacas, Rocío, Soriano, Virtudes, Garicano, Fernando, Lecumberri, M. José, Rodríguez de la Borbolla, María, Majem, Margarita, Pérez-Ruiz, Elisabeth, González-Cao, María, Oramas, Juana, Magdaleno, Alejandra, Fra, Joaquín, Martín-Carnicero, Alfonso, Corral, Mónica, Puértolas, Teresa, Ramos-Ruiz, Ricardo, Dittmann, Antje, Nanni, Paolo, Fresno Vara, Juan Ángel, Espinosa, Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486782/
https://www.ncbi.nlm.nih.gov/pubmed/37686682
http://dx.doi.org/10.3390/cancers15174407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486782/
https://www.ncbi.nlm.nih.gov/pubmed/37686682
http://dx.doi.org/10.3390/cancers15174407

Ejemplares similares